Cutaneous findings related to cardiovascular disorders

George, William M.

doi:10.1046/j.1365-4362.1998.00356.x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Dermatologic Markers Of Lipid Derangement Dermatologic Marke1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2009

Publication Types

Select...

Article1

Other1

Book1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[15] The most frequent hyperlipidemia associated with xanthelasma is type IIa. [16] Less frequently, types IIb, III, and IV are found. [16] Isolated xanthelasmata are often treated with destructive modalities, like trichloroacetic acid, electrocautery, surgical excision, [17] carbon dioxide laser, [18] pulsed dye laser, [19] and erbium:YAG laser.…”

Section: Dermatologic Markers Of Lipid Derangement Dermatologic Markementioning

confidence: 99%

Management of hyperlipidemias: An update

Ranjan¹

2009

Indian J Dermatol Venereol Leprol

View full text Add to dashboard Cite

The discovery of the key enzymes, receptors, and transporters in cholesterol biosynthesis has enabled us to assemble fragments of knowledge concerning lipids and lipoproteins into dynamic pathways, leading to the development of a multitude of lipid-lowering drugs. After a brief recapitulation of the pathways of cholesterol metabolism and the dermatologic manifestations of lipid derangement, we shall review drugs which modify intestinal cholesterol and bile-acid reabsorption, and hepatic lipoprotein biosynthesis and catabolism. The current literature is examined to determine future therapeutic targets in lipid metabolism, as well as the role of traditional foods as lipid-lowering agents. The latest National Cholesterol Education Program guidelines for managing hypercholesterolemia are also discussed.

show abstract